Katie L. Lewis

Katie L. Lewis

Auto-generated profile, based on publicly available information

Katie L. Lewis

Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
KLKatie L. Lewis
Katie L. Lewis
GHGillian W. Hooker
Gillian W. Hooker
PCPhilip D. Connors
Philip D. Connors
THTravis C. Hyams
Travis C. Hyams
MWMartha F. Wright
Martha F. Wright
BBBarbara B. Biesecker
Barbara B. Biesecker
This study investigated how genome sequencing results affect health behaviors, affect, and communication. We report on 29 participants who received a sequence result in the ClinSeq study, a cohort of well-educated, postreproductive volunteers. A mixed-methods design was used to explore respondents’ use, communication, and perceived utility of results. Most participants (72%) shared their result with at least one health-care provider, and 31% reported subsequent changes in the health care they received. Participants scored high on the Positive Experiences subscale and low on the Distress subscale of a modified version of the Multidimensional Impact of Cancer Risk Assessment. The majority (93%) shared their result with at least one family member. Participants described deriving personal utility from their results. This article is the first to describe research participants’ reactions to actionable sequencing results. Our findings suggest clinical and personal benefit from receiving sequencing results, both of which may contribute to improved health for the recipients. Given the participants’ largely positive or neutral affective responses and disclosure of their results to physicians and relatives, health-care providers should redirect concern from the potential for distress and attend to motivating patients to follow their medical recommendations. Genet Med 18 6, 577–583.

17 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KLKatie L. Lewis
Katie L. Lewis
PHPaul K. J. Han
Paul K. J. Han
GHGillian W. Hooker
Gillian W. Hooker
WKWilliam M. P. Klein
William M. P. Klein
LBLeslie G. Biesecker
Leslie G. Biesecker
BBBarbara B. Biesecker
Barbara B. Biesecker
Genome sequencing is a novel clinical tool that has the potential to identify genetic origins of disease. However, the complexities of this new technology are significant and little is known about its integration into clinical care, and its potential adoption by patients. Expectations of its promise for personalized medicine are high and it is important to properly match expectations to the realities of the test. The NIH ClinSeq cohort study pilots the integration of genome sequencing into clinical research and care to assess the technical, medical and socio-behavioral aspects of implementing this technology. Over 950 adults ages 45-65 have been enrolled and clinically phenotyped. As an initial study, we describe the personality traits of ClinSeq participants, and explore how these traits compare to those that characterize early adopters of other new technologies. Our analysis was conducted on responses from 630 members of the cohort who completed a baseline survey on health cognitions, affect, health-related behaviors and personality traits, prior to receipt of any genome sequencing results. The majority of participants were white (90.5%), had at least a college degree (86.5%), and had at least one biological child (74.6%). Members of this ClinSeq sample were found to be high in dispositional optimism and resilience. Their high SES paralleled that of other early adopters of new technology. These attributes may contribute to participants’ expectations for favorable outcomes and willingness to take higher risks when compared to the general population. These characteristics may distinguish those who are most likely to pursue genome sequencing and be indicative of their psychological resources to manage returned results.

1 November 2018 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
KLKatie L. Lewis
Katie L. Lewis
AHAlexis R. Heidlebaugh
Alexis R. Heidlebaugh
SESandra Epps
Sandra Epps
PHPaul K.J. Han
Paul K.J. Han
KFKristen Fishler
Kristen Fishler
LBLeslie G. Biesecker
Leslie G. Biesecker

1 April 2018 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KLKatie L. Lewis
Katie L. Lewis
KUKendall L. Umstead
Kendall L. Umstead
JJJennifer Johnston
Jennifer Johnston
IMIlana M. Miller
Ilana M. Miller
LTLydia J. Thompson
Lydia J. Thompson
BBBarbara B. Biesecker
Barbara B. Biesecker

1 May 2021 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KLKatie L. Lewis
Katie L. Lewis
ETErin Turbitt
Erin Turbitt
PCPriscilla A. Chan
Priscilla A. Chan
SESandra Epps
Sandra Epps
BBBarbara B. Biesecker
Barbara B. Biesecker
LBLeslie G. Biesecker
Leslie G. Biesecker

13 September 2016 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
PDF file
KLKatie L. Lewis
Katie L. Lewis
LELori A. H. Erby
Lori A. H. Erby
ABAmanda L. Bergner
Amanda L. Bergner
ERE. Kate Reed
E. Kate Reed
MJMaria R. Johnson
Maria R. Johnson
MWMeredith A. Weaver
Meredith A. Weaver